Affiliation:
1. Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung 40614
Abstract
Lactobacillus acidophilus, a strain of lactic acid bacteria widely used as a probiotic microorganism, has been extensively employed in developing probiotic products including in effervescent granules. This study's objectives were to ensure that the resultant granules possessed the desired physical attributes and retained the requisite viability of lactic acid bacteria. A wet granulation method was used. The formula was physically evaluated and analyzed using Design Expert software, followed by gram staining and bacterial harvesting. Gram staining verification demonstrated the gram-positive nature of the pure L. acidophilus bacterial isolates, as evidenced by their consistent purple coloration and characteristic basil shape. Evaluation of physical properties revealed organoleptic attributes such as granular shape, white coloration devoid of odor, flow rate of 1.497 g/sec, an angle of repose at 40.75o, compressibility of 11.45%, drying loss of 0.62%, and a foam height of 3.075 cm, consistently meeting the stipulated criteria. Furthermore, formula I, II, and III preserved L. acidophilus bacteria after being converted into effervescent granules, as evidenced by viable lactic acid bacteria counts, with formula I (412.5 x 101 cfu/g), formula II (422.7 x 101 cfu/g), and formula III (highest at 522.7 x 101 cfu/g). The formula I emerges as the most favorable effervescent granules containing L. acidophilus 3%; polyvinylpyrrolidone 3%; citric acid 0.3 %; tartaric acid 49.7%; sodium bicarbonate 25% and lactose as filler. Based on the finding, this probiotic effervescent granules has the potential to be developed as a daily supplement, especially for flora normal stabilization.
Reference39 articles.
1. Tanujaya D, Riniwasih L. Formulasi dan Uji Stabilitas Fisik Tablet Effervescent yang Mengandung Bakteri Probiotik Lactobacillus Bulgariscus dengan Metode Granulasi Basah. Indoensia Nat Res Pharm J. 2019;4(2):pp.101-112.
2. Halder D, Mandal M, Chatterjee SS, Pal NK, Mandal S. Indigenous probiotic Lactobacillus isolates presenting antibiotic like activity against human pathogenic bacteria. Biomedicines. 2017;5(2):1â11.
3. Surendran Nair M, Amalaradjou MA, Venkitanarayanan K. Antivirulence Properties of Probiotics in Combating Microbial Pathogenesis [Internet]. Vol. 98, Advances in Applied Microbiology. Elsevier Ltd; 2017. 1â29 p. Available from: http://dx.doi.org/10.1016/bs.aambs.2016.12.001
4. Ali MS, Lee EB, Hsu WH, Suk K, Sayem SAJ, Ullah HMA, et al. Probiotics and Postbiotics as an Alternative to Antibiotics: An Emphasis on Pigs. Pathogens. 2023;12(7).
5. Cotter PD, Ross RP, Hill C. Bacteriocins-a viable alternative to antibiotics? Nat Rev Microbiol [Internet]. 2013;11(2):95â105. Available from: http://dx.doi.org/10.1038/nrmicro2937